Genocea Biosciences (NASDAQ:GNCA)’s share price plunged -2.42% or -0.03 to reach at $1.21 during previous trading session. A total of 1.54 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.13 Million shares. Genocea Biosciences (NASDAQ:GNCA) has a market capitalization of $95.72 Million and most recently 79.11 Million outstanding shares have been calculated.

According to sentiments of 2 analysts the mean estimates of short term price target for the company’s stock is marked at $8.5. The most optimistic analyst sees the stock reaching $12 while the most conventional predicts the target price at $5.

In terms of Buy/Sell recommendations, 4 analysts have a consensus rating of 1.2 on the shares of Genocea Biosciences (NASDAQ:GNCA). Out of rating recommendations 2 have given the stock a Buy while 4 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Genocea Biosciences (NASDAQ:GNCA)’s distance from 20 day simple moving average is 0.1651 along with distance from 50 day simple moving average of 0.99 whereas its distance from 200 day simple moving average is 1.79. Genocea Biosciences (NASDAQ:GNCA)’s price distance from 52-week high is -83.4 and from 52-week low is 52.93. The stock hit its 52-week high price on 04/25/17, and 52-week low price on 01/17/18. The stock’s 52-week price fluctuated within the range of $7.29 – $0.79.

Genocea Biosciences (NASDAQ:GNCA)’s shares climbed 17.48% in the past week and soared 23.47% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -77.59% while its year to date performance is at 4.31%.

While taking a glance at financials, we can look at a number of key indicators. Genocea Biosciences (NASDAQ:GNCA) has a Return on Assets (ROA) of -157.8. The company currently has a Return on Equity (ROE) of -454.3 and a Return on Investment (ROI) of 0. Average true range (ATR-14) of the company sets at 0.07, along with its weekly and monthly volatility of 7.66% and 5.91% respectively. Relative strength index (RSI-14) for Genocea Biosciences (NASDAQ:GNCA) is at 65.57. Beta value of the stock stands at 1.26.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 0.8 along with current ratio for most recent quarter of 0.8. Total debt to equity ratio of Genocea Biosciences (NASDAQ:GNCA) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of Mitel Networks Corp (NASDAQ:MITL) soared 0.93% or 0.08 to reach at $8.67 during previous trading session. Mitel Networks Corp (NASDAQ:MITL) has a market capitalization of $993.41 Million and most recently 114.58 Million outstanding shares have been calculated. A total of 1.53 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.23 Million shares.

According to 6 analysts Mitel Networks Corp (NASDAQ:MITL)’s price will reach at $12.08 during 52 weeks. Stock’s minimum price target estimates has been figured out at $9.5 while the maximum price target forecast is established at $15.

According to the recommendations from 3 analysts stock has mean rating of 1.33 on the shares of Mitel Networks Corp (NASDAQ:MITL). Out of rating recommendations 2 have given the stock a Buy while 4 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Mitel Networks Corp (NASDAQ:MITL) climbed 8.1% in the past week and soared 4.33% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 9.06% while its year to date performance is at 5.35%.

Mitel Networks Corp (NASDAQ:MITL)’s 52-week price fluctuated within the range of $9.39 – $6.21. Its price distance from 52-week high is -7.67 and from 52-week low is 39.61. The stock hit its 52-week high price on 02/21/18, and 52-week low price on 05/08/17. Mitel Networks Corp (NASDAQ:MITL)’s distance from 20 day simple moving average is0.0241 along with distance from 50 day simple moving average of 8.63 whereas its distance from 200 day simple moving average is 8.31.

Total debt to equity ratio of Mitel Networks Corp (NASDAQ:MITL) for most recent quarter is 1.82 whereas long term debt to equity ratio for most recent quarter is 1.77. The company’s price to free cash flow for trailing twelve months is 56.77. Its quick ratio for most recent quarter is 0.8 along with current ratio for most recent quarter of 1.

Average true range (ATR-14) of the company sets at 0.32, along with its weekly and monthly volatility of 4.53% and 3.84% respectively. Relative strength index (RSI-14) for Mitel Networks Corp (NASDAQ:MITL) is at 55.37. Beta value of the stock stands at 2.61. Mitel Networks Corp (NASDAQ:MITL) has a Return on Assets (ROA) of -3.6. The company currently has a Return on Equity (ROE) of -14.6 and a Return on Investment (ROI) of -3.3.